Jamison Private Wealth Management Inc. boosted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 16.1% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 4,539 shares of the medical equipment provider's stock after acquiring an additional 631 shares during the period. Jamison Private Wealth Management Inc.'s holdings in Intuitive Surgical were worth $2,369,000 as of its most recent filing with the SEC.
Several other institutional investors and hedge funds also recently made changes to their positions in the business. Mirador Capital Partners LP lifted its holdings in Intuitive Surgical by 1.4% during the third quarter. Mirador Capital Partners LP now owns 3,526 shares of the medical equipment provider's stock worth $1,732,000 after acquiring an additional 50 shares in the last quarter. M.E. Allison & CO. Inc. acquired a new stake in shares of Intuitive Surgical during the fourth quarter worth about $449,000. Seilern Investment Management Ltd bought a new position in shares of Intuitive Surgical during the 4th quarter valued at about $82,517,000. Exome Asset Management LLC grew its position in shares of Intuitive Surgical by 16.8% in the 3rd quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider's stock valued at $3,649,000 after purchasing an additional 1,069 shares during the period. Finally, Consolidated Planning Corp increased its stake in Intuitive Surgical by 17.4% during the 3rd quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider's stock worth $3,979,000 after purchasing an additional 1,198 shares in the last quarter. Institutional investors own 83.64% of the company's stock.
In related news, EVP Robert Desantis sold 188 shares of the company's stock in a transaction dated Tuesday, October 29th. The shares were sold at an average price of $506.52, for a total value of $95,225.76. Following the transaction, the executive vice president now owns 5,506 shares in the company, valued at approximately $2,788,899.12. This represents a 3.30 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Jamie Samath sold 22,903 shares of the firm's stock in a transaction that occurred on Friday, November 8th. The stock was sold at an average price of $525.00, for a total transaction of $12,024,075.00. Following the sale, the insider now owns 8,757 shares of the company's stock, valued at $4,597,425. This trade represents a 72.34 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 42,475 shares of company stock worth $22,070,807 over the last 90 days. Company insiders own 0.90% of the company's stock.
Several equities research analysts have recently issued reports on the stock. Royal Bank of Canada increased their price objective on shares of Intuitive Surgical from $525.00 to $555.00 and gave the stock an "outperform" rating in a research report on Friday, October 18th. BTIG Research increased their target price on Intuitive Surgical from $535.00 to $561.00 and gave the stock a "buy" rating in a report on Tuesday, November 26th. Oppenheimer restated a "market perform" rating on shares of Intuitive Surgical in a report on Friday, October 18th. Evercore ISI reiterated a "cautious" rating on shares of Intuitive Surgical in a report on Friday, October 18th. Finally, Citigroup lifted their target price on Intuitive Surgical from $640.00 to $711.00 and gave the company a "buy" rating in a research report on Friday. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and fifteen have issued a buy rating to the company's stock. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $583.83.
View Our Latest Report on ISRG
Shares of ISRG stock opened at $584.05 on Friday. Intuitive Surgical, Inc. has a 52-week low of $364.17 and a 52-week high of $616.00. The stock has a market cap of $208.03 billion, a price-to-earnings ratio of 93.90, a PEG ratio of 5.19 and a beta of 1.39. The firm's 50-day moving average is $547.16 and its 200-day moving average is $504.35.
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Intuitive Surgical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.
While Intuitive Surgical currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.